Open AccessDrug‐induced vasculitis: Thiazide or the COVID ‐19 vaccine, which one is guilty? A case report and literature review
Author(s) -
Hekmat Manoochehr,
Jafari Naeini Sepideh,
Abbasi Zahra,
Dadkhahfar Sahar
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5978
Subject(s) - medicine , thiazide , drug , covid-19 , vasculitis , virology , dermatology , intensive care medicine , pharmacology , disease , infectious disease (medical specialty) , diuretic , outbreak
A middle‐aged woman with a history of COVID‐19 vaccine administration and valve replacement surgery was admitted with bilateral palpable purpuric lesions in the lower extremities and headache. Based on the initial diagnosis of vasculitis, corticosteroid therapy was initiated, which led to the resolution of skin lesions.